Annual EBITDA
$17.12B$3.70B+27.56%
Summary
- Current Value
- As of today, AZN annual EBITDA is $17.12B, up +27.56% on
- Historical Performance
- AZN annual EBITDA is up +234.85% over the past 3 years, and up +155.08% over the past 5 years
- All-Time High Comparison
- AZN annual EBITDA is currently at its all-time high
- 3-Year Low Comparison
- AZN annual EBITDA is +88.45% above its 3-year low of $9.09B reached on an earlier date
- Sector Comparison
- AZN annual EBITDA is higher than 99.32% of companies in Healthcare sector
EBITDA Chart
Add series to chart1/6
Series
SUGGESTED SERIES
Performance
| Metric | Date | Value | 1Y | 3Y | 5Y | 15Y |
|---|---|---|---|---|---|---|
| Annual EBITDA | $17.12B | +27.6% | +234.8% | +155.1% | +22.8% | |
| Quarterly EBITDA | $5.09B | +10.6% | +93.4% | +167.8% | +81.2% | |
| TTM EBITDA | $19.25B | +21.6% | +104.6% | +141.8% | +43.1% | |
| Price | $91.57 | +38.2% | +31.2% | +80.6% | +287.4% | |
| PE Ratio | 30.41 | +3.2% | -54.0% | -27.0% | +250.8% | |
| Annual Revenue | $54.10B | +18.1% | +43.0% | +121.8% | +65.9% | |
| Annual EPS | $2.25 | +18.1% | +5643.4% | +338.8% | -12.7% | |
| Annual EBIT | $10.43B | +22.9% | +932.0% | +253.7% | -12.0% | |
| Annual Net Income | $7.04B | +18.2% | +6025.2% | +474.1% | -6.1% |
EBITDA Highs
| Period | High | Date | Current |
|---|---|---|---|
| 3Y | $17.12B | at high | |
| 5Y | $17.12B | at high | |
| All | $17.12B | at high |
EBITDA Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 3Y | $9.09B | N/A | +88.5% |
| 5Y | $5.11B | +234.8% | |
| All | $687.06M | +2391.9% |
EBITDA History
FAQ
What is the current annual EBITDA of AZN?
As of today, AZN annual EBITDA is $17.12B
What is 1-year change in AZN annual EBITDA?
AZN annual EBITDA is up +27.56% year-over-year
What is 3-year change in AZN annual EBITDA?
AZN annual EBITDA is up +234.85% over the past 3 years
How far is AZN annual EBITDA from its all-time high?
AZN annual EBITDA is currently at its all-time high
How does AZN annual EBITDA rank versus sector peers?
AZN annual EBITDA is higher than 99.32% of companies in Healthcare sector
When is AZN next annual earnings release?
The next annual earnings release for AZN is on
Quarterly EBITDA
$5.09B$230.38M+4.74%
Summary
- Current Value
- As of today, AZN quarterly EBITDA is $5.09B, up +4.74% on
- Historical Performance
- AZN quarterly EBITDA is up +10.61% year-over-year, and up +93.36% over the past 3 years
- All-Time High Comparison
- AZN quarterly EBITDA is currently at its all-time high
- 3-Year Low Comparison
- AZN quarterly EBITDA is +94.92% above its 3-year low of $2.61B reached on
- Sector Comparison
- AZN quarterly EBITDA is higher than 99.37% of companies in Healthcare sector
Performance
| Metric | Date | Value | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|
| Quarterly EBITDA | $5.09B | +4.7% | +10.6% | +93.4% | +167.8% | |
| Annual EBITDA | $17.12B | – | +27.6% | +234.8% | +155.1% | |
| TTM EBITDA | $19.25B | +2.6% | +21.6% | +104.6% | +141.8% | |
| Price | $91.57 | +7.3% | +38.2% | +31.2% | +80.6% | |
| PE Ratio | 30.41 | +7.3% | +3.2% | -54.0% | -27.0% | |
| Quarterly Revenue | $15.10B | +3.2% | +11.3% | +37.5% | +123.7% | |
| Quarterly EPS | $0.81 | +1.4% | +76.3% | +53.3% | +226.8% | |
| Quarterly EBIT | $3.55B | +2.8% | +27.5% | +173.4% | +222.9% | |
| Quarterly Net Income | $2.52B | +1.7% | +75.8% | +53.5% | +287.1% |
Quarterly EBITDA Highs
| Period | High | Date | Current |
|---|---|---|---|
| 1Y | $5.09B | at high | |
| 3Y | $5.09B | at high | |
| 5Y | $5.09B | at high | |
| All | $5.09B | at high |
Quarterly EBITDA Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 1Y | $4.33B | N/A | +17.5% |
| 3Y | $2.61B | +94.9% | |
| 5Y | $1.82B | +179.4% | |
| All | -$4.83B | +205.4% |
Quarterly EBITDA History
FAQ
What is the current quarterly EBITDA of AZN?
As of today, AZN quarterly EBITDA is $5.09B
What is AZN quarterly EBITDA most recent change?
AZN quarterly EBITDA was up +4.74% on September 30, 2025
What is 1-year change in AZN quarterly EBITDA?
AZN quarterly EBITDA is up +10.61% year-over-year
How far is AZN quarterly EBITDA from its all-time high?
AZN quarterly EBITDA is currently at its all-time high
How does AZN quarterly EBITDA rank versus sector peers?
AZN quarterly EBITDA is higher than 99.37% of companies in Healthcare sector
When is AZN next earnings release?
The next earnings release for AZN is on
TTM EBITDA
$19.25B$488.24M+2.60%
Summary
- Current Value
- As of today, AZN TTM EBITDA is $19.25B, up +2.60% on
- Historical Performance
- AZN TTM EBITDA is up +21.58% year-over-year, and up +104.58% over the past 3 years
- All-Time High Comparison
- AZN TTM EBITDA is currently at its all-time high
- 3-Year Low Comparison
- AZN TTM EBITDA is +102.51% above its 3-year low of $9.51B reached on an earlier date
- Sector Comparison
- AZN TTM EBITDA is higher than 99.28% of companies in Healthcare sector
Performance
| Metric | Date | Value | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|
| TTM EBITDA | $19.25B | +2.6% | +21.6% | +104.6% | +141.8% | |
| Annual EBITDA | $17.12B | – | +27.6% | +234.8% | +155.1% | |
| Quarterly EBITDA | $5.09B | +4.7% | +10.6% | +93.4% | +167.8% | |
| Price | $91.57 | +7.3% | +38.2% | +31.2% | +80.6% | |
| PE Ratio | 30.41 | +7.3% | +3.2% | -54.0% | -27.0% | |
| TTM Revenue | $58.07B | +2.7% | +13.4% | +28.3% | +116.4% | |
| TTM EPS | $3.01 | +13.1% | +44.7% | +361.3% | +216.7% | |
| TTM EBIT | $12.71B | +6.4% | +25.1% | +294.8% | +220.3% | |
| TTM Net Income | $9.40B | +13.1% | +44.7% | +360.1% | +289.2% |
TTM EBITDA Highs
| Period | High | Date | Current |
|---|---|---|---|
| 1Y | $19.25B | at high | |
| 3Y | $19.25B | at high | |
| 5Y | $19.25B | at high | |
| All | $19.25B | at high |
TTM EBITDA Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 1Y | $17.55B | N/A | +9.7% |
| 3Y | $9.51B | N/A | +102.5% |
| 5Y | $8.12B | N/A | +137.2% |
| All | -$421.81M | +4663.8% |
TTM EBITDA History
FAQ
What is the current TTM EBITDA of AZN?
As of today, AZN TTM EBITDA is $19.25B
What is AZN TTM EBITDA most recent change?
AZN TTM EBITDA was up +2.60% on September 30, 2025
What is 1-year change in AZN TTM EBITDA?
AZN TTM EBITDA is up +21.58% year-over-year
How far is AZN TTM EBITDA from its all-time high?
AZN TTM EBITDA is currently at its all-time high
How does AZN TTM EBITDA rank versus sector peers?
AZN TTM EBITDA is higher than 99.28% of companies in Healthcare sector
When is AZN next earnings release?
The next earnings release for AZN is on
EBITDA Formula
Data Sources & References
- AZN Official Website www.astrazeneca.com
- Most Recent Quarterly Report (10-Q) www.sec.gov/Archives/edgar/data/901832/000165495425012630/0001654954-25-012630-index.htm
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/901832/000110465925014750/0001104659-25-014750-index.htm
- AZN Profile on Yahoo Finance finance.yahoo.com/quote/AZN
- AZN Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/azn